BeOne Medicines Ltd. — Director's Dealing 2018

Nov 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2018-11-27

Reporting Person: Wang Xiaodong (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-27	Ordinary Shares	G	89999	—	Disposed	7773608	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	224372	Indirect
Ordinary Shares	5000000	Indirect

Footnotes

F1: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5.

F2: These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.